CEO and CFO · ORAGENICS INC · ORAGENICS INC — Employee Stock Option (right to buy)
Side
A
Value
—
Shares
250.0K
Price
—
Executed
Dec 11, 2025
Disclosed
Dec 15, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 11 executedDec 15, 2025 disclosed
OGEN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ORAGENICS INC — Employee Stock Option (right to buy)
Ticker
OGEN
Shares
250.0K
Price per share
$0
Execution date (reported)
Dec 11, 2025
Owned after transaction
250.0K shares
Days from execution to publication
4
What this establishes
Huffman Janet filed this Form 4 reporting a grant or award of OGEN on Dec 11, 2025. It became public on Dec 15, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CEO and CFO
Huffman Janetcik:0001866284
Issuer
ORAGENICS INCcik:0001174940
Revision history · 0
No field has changed since this record was first ingested.
